A test flight of Japan’s new passenger jet was aborted yesterday for the second time in two days because of an air conditioning defect, its maker said.
A Mitsubishi Regional Jet (MRJ) on Saturday left Nagoya Airfield in central Japan for the US, but soon turned back due to air conditioning problems.
The plane took off again yesterday, but problems “in the same air conditioning monitoring system” caused it to return, Mitsubishi Heavy Industries Ltd and its subsidiary, Mitsubishi Aircraft Corp, said in a joint statement.
Photo: AFP
“After the jet returned yesterday, we checked the system and changed parts. After confirming that there was no problem in a test on the ground, today we launched the flight again, but the same problem occurred,” Mitsubishi Heavy spokesman Yuji Sawamura said.
The MRJ, which can seat as many as 92 people, is the first of four that the firm will fly to US for testing as the company works toward getting certification in the world’s largest economy.
The aircraft made its first flight in November last year and has been undergoing tests since.
Development of the MRJ has suffered a series of delays. In December last year, Mitsubishi Heavy said it was postponing delivery of the planes by one year to the second quarter of 2018 for system software upgrades and other design changes.
The twin-engine MRJ marks a new chapter in Japan’s aviation sector, which last built a commercial airliner in 1962 — the YS-11 turboprop, made by Nihon Aircraft Manufacturing Corp, a consortium that included Mitsubishi Heavy, Kawasaki Heavy Industries Ltd and Fuji Heavy Industries Ltd. Production was stopped in 1974 after 182 of the planes were sold.
The MRJ will compete with other regional passenger jet manufacturers such as Brazil’s Embraer SA and Canada’s Bombardier Inc.
Mitsubishi Heavy unveiled the jet in October last year and has received more than 400 orders.
Additional reporting by Bloomberg
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained